Amitell Capital’s Elevance Health ELV Stock Holding History

Amitell Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,180	Closed	-$2.32M	–	33
2025 Q3	$2.32M	Buy	+7,180	New	+$2.23M	1.41%	29

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Amitell Capital's ELV Position: Q4 2025 in Review

Amitell Capital sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 7,180 shares — an estimated $2.32M sold.

Amitell Capital first reported a position in ELV in Q3 2025 and held it in 1 quarter. The position peaked at $2.32M in Q3 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

Amitell Capital reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
Amitell Capital sold 7,180 Elevance Health shares in Q4 2025, an estimated $2.32M.
Amitell Capital first reported a position in Elevance Health in Q3 2025 and held it in 1 quarter.
Amitell Capital's Elevance Health position peaked at $2.32M in Q3 2025.
1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Amitell Capital's 13F filing for Q4 2025, filed 12 Feb 2026.